Core Insights - Visionary Holdings Inc. has announced significant corporate developments, including a new leadership team and a strategic shift towards the anti-aging high-end medical aesthetics sector [1][4]. Governance and Leadership - A new nine-member Board of Directors was elected during the Annual General Meeting on October 29, 2025, with Mr. Xiyong Hou as CEO, Mr. Jun Huang as Co-CEO, Mr. Robert Jay Lees as COO, and Ms. Katy Liu as CFO [2]. - Mr. William T. Chai has been elected as Chairman of the Board, and Mr. Donald M. Kealey serves as Vice Chairman [2]. Audit and Compliance - Assentsure PAC has been reappointed as the Company's auditor for the fiscal years 2025-2026 [3]. Strategic Transformation - Visionary Holdings has completed a strategic transformation focusing on anti-aging high-end medical aesthetics, with its traditional education business now a supplementary division [4]. - The Company is prioritizing global technology R&D and market expansion in this high-growth sector [4]. Key Partnerships - In September 2025, Visionary Holdings established two major partnerships: - A global R&D partnership with Jiangsu Yike Regenerative Medicine Technology Co., Ltd. to develop and market medical aesthetics products [5]. - A joint venture with Anhui Weikang Kangling Medical Technology Co., Ltd. to build an "Anti-Aging High-End Medical Aesthetics and Health Center" in Toronto, Canada [5]. Financial Reporting - The draft of the Annual Report for the fiscal year ended March 31, 2025, is complete and undergoing final internal review, with plans to file with the U.S. Securities and Exchange Commission by January 12, 2026 [6]. Company Vision - The CEO stated that the successful completion of the strategic pivot marks a new era for Visionary Holdings, positioning the Company for sustained growth and long-term value for shareholders [7].

Core Insights - Visionary Holdings Inc. has appointed Ms. Wenxuan Cai as the CEO of its subsidiary, Visionary Health Technology Group Limited in Hong Kong, effective immediately [1] - The company has established a new wholly owned subsidiary in Nanjing, China, focusing on sales execution and market development, marking a shift from strategic positioning to active revenue generation [2] Leadership and Market Strategy - Ms. Cai brings nearly two decades of experience in market expansion and sales organization building, particularly in the healthcare sector, and will focus on enhancing sales infrastructure and execution [3][8] - The Nanjing entity will serve as a frontline commercial platform for regional sales operations, completing a fully integrated commercial structure alongside the Hong Kong platform [4] Commercialization Efforts - The company has transitioned from conceptual planning to operational commercialization, with a strong emphasis on building high-performance sales teams and translating market strategies into commercial results [5][6] - Recent milestones include strategic entry into cellular rejuvenation and aesthetic treatment markets, completion of global technology licensing, and the launch of a diversified product portfolio [9] Growth Potential - With leadership, products, and sales infrastructure aligned, the company is well-positioned to capitalize on the growing demand for advanced cellular-based and aesthetic solutions across Asia [7]

Core Insights - Premarket trading is showing notable activity with early price movements indicating potential opportunities before the market opens [1] Premarket Gainers - Mawson Infrastructure Group Inc. (MIGI) is up 10% at $5.65 [3] - Mingteng International Corporation Inc. (MTEN) is up 9% at $1.88 [3] - Barnwell Industries, Inc. (BRN) is up 9% at $1.20 [3] - Amentum Holdings, Inc. (AMTM) is up 8% at $27.57 [3] - Antelope Enterprise Holdings Limited (AEHL) is up 8% at $2.75 [3] - Protagenic Therapeutics, Inc. (PTIX) is up 8% at $2.43 [3] - Envirotech Vehicles, Inc. (EVTV) is up 8% at $1.18 [3] - Vir Biotechnology, Inc. (VIR) is up 6% at $6.49 [3] - Zoom Communications Inc. (ZM) is up 5% at $82.73 [3] - Core AI Holdings (CHAI) is up 5% at $2.68 [3] Premarket Losers - Foxx Development Holdings Inc. (FOXX) is down 13% at $4.00 [4] - Jaguar Health, Inc. (JAGX) is down 11% at $1.13 [4] - AlphaTON Capital Corp. (ATON) is down 7% at $2.54 [4] - Semtech Corporation (SMTC) is down 6% at $65.81 [4] - Cypherpunk Technologies Inc. (CYPH) is down 5% at $1.73 [4] - SunPower Inc. (SPWR) is down 5% at $1.59 [4] - Visionary Holdings Inc. (GV) is down 4% at $1.23 [4] - Gelteq Limited (GELS) is down 4% at $1.01 [4] - Capricor Therapeutics, Inc. (CAPR) is down 3% at $4.47 [4] - Mobile-Network Solutions (MNDR) is down 3% at $2.82 [4]

Core Insights - eXp Realty's CEO Leo Pareja has been recognized in The 2025 MarketWatch 25 list for his innovative leadership in the real estate industry [2][3][4] - Pareja's vision focuses on transparency, accessibility, and empowerment, aiming to build trust and enhance agent success while creating a connected experience for consumers globally [3][4] Company Overview - eXp World Holdings, Inc. is the parent company of eXp Realty and SUCCESS Enterprises, with eXp Realty being the largest independent real estate brokerage globally, boasting over 83,000 agents across 28 countries [6] - The company operates as a cloud-based, agent-centric brokerage, offering industry-leading commission splits, revenue share, equity ownership opportunities, and a global network for agents [6] Leadership and Recognition - Leo Pareja's leadership is characterized by innovation and collaboration, which are core values of eXp Realty, emphasizing agent empowerment and market transparency [4][5] - Pareja's inclusion in the MarketWatch 25 highlights eXp Realty's role in challenging traditional real estate norms and shaping the future of the industry [4][5]

Core Insights - Visionary Holdings Inc. has officially launched its medical-grade stem cell anti-aging product line, targeting the Chinese mainland and broader Asian markets [1][2] - This launch follows the company's entry into the stem cell and medical aesthetics sector and a strategic partnership with Jiangsu Yike Regenerative Medicine Co., Ltd. [2][3] Product Lines and Value Model - The anti-aging product portfolio includes three major categories: Life Rejuvenation Program, Precision Repair Package, and Premium Personalized Program [6] - The Life Rejuvenation Program combines mesenchymal stem cells, NK cell therapy, and AI-based diagnostics, aimed at high-net-worth individuals [6] - The Precision Repair Package integrates targeted stem cell therapy and blood purification for clients with specific conditions [6] - The Premium Personalized Program offers full-genome sequencing and customized health management for ultra-high-net-worth clients [6] Commercialization Strategy - The new products will be operated through the Asia-Pacific headquarters in Hong Kong, initially launching in Hong Kong, Singapore, and the Chinese mainland [4] - The company plans to establish a joint venture for localized manufacturing and validation of stem cell products [7] - A cross-border sales and distribution network will be built, covering mainland China, Hong Kong, Southeast Asia, and expanding into Canada, the United States, and Mexico [7] Management Perspective - The CEO of Visionary Holdings emphasized that the launch marks a significant milestone in converting technological assets into commercial value [4] - The company anticipates that this product line will drive profitability in upcoming fiscal years and enhance its visibility in global capital markets [5]

Core Insights - Visionary Holdings Inc. successfully convened the First Meeting of the Fourth Board of Directors, adopting all core proposals unanimously, which establishes a solid institutional foundation for the Company's future operations [1][2]. Governance Structure - The meeting resulted in the election of key positions: Mr. William T. Chai as Chairman, Mr. Kealey Donald M as Vice Chairman, Mr. Rusheng Wu as Managing Director, and Mr. Jun Huang as Executive Director, with Ms. Yongqiu Wang appointed as Company Secretary [2][3]. - Four specialized committees were established: Audit Committee, Nomination Committee, Compensation Committee, and Investment Committee, each with a focus on enhancing decision-making and risk control capabilities [3][4]. Management Team - A new senior management team was appointed, including Mr. Xiyong Hou as CEO, Mr. Jun Huang as Co-CEO, Mr. Robert Jay LEES as COO, and Ms. Xiaolan Liu as CFO, aimed at improving operational quality and global expansion [4][5]. Governance Improvement - The meeting adopted various procedural documents to clarify powers and responsibilities, standardize processes, and support efficient operations, with a focus on compliance and operational optimization [5][6]. Strategic Focus - The newly elected Chairman emphasized the commitment to compliance, investor interests, and value creation in high-end stem cell aesthetics and big health technology, aiming for sustainable development and industry ecosystem upgrades [6][7].

Core Points - Visionary Holdings Inc. successfully held its 2025 Annual General Meeting (AGM) with 97.79% of voting rights represented, exceeding quorum requirements [1] - All core agenda items, including board renewal and auditor reappointment, were approved with an overwhelming majority, establishing a solid governance foundation for the upcoming fiscal year [2] I. Board Renewal - The company renewed its Board of Directors, adhering to U.S. SEC and Nasdaq standards for director independence, with 16 candidates selected from 18 profiles [3] - Nine candidates were officially elected to the 4th Session of the Board, receiving over two-thirds of affirmative votes, with their term lasting until the end of the 2026 AGM [4] - The new board members bring diverse professional backgrounds, enhancing strategic decision-making and governance structure [5] II. Reappointment of Auditors - The AGM approved the reappointment of Assentsure PAC as the auditor for the 2025-2026 fiscal year, ensuring compliance with U.S. SEC and Nasdaq audit supervision requirements [6] - Assentsure PAC has a strong track record, having completed the previous fiscal year's audit efficiently, and will continue to ensure accurate financial disclosures [7] III. Review of Annual Reports - The financial report for the 2024-2025 fiscal year was approved, highlighting that 78% of revenue came from core businesses, with a 100% year-on-year growth in net profit from new health projects [9] - The company maintained total assets of USD 68,792 thousand and an asset-liability ratio of 80%, indicating a stable financial structure [9] - Strategic progress included establishing branches in China, acquiring new clients, and enhancing international brand influence [10] IV. Confirmation of Statutory Matters - The AGM confirmed the legality of the board election results, the appointment of Assentsure PAC, and the compliance of the 2024-2025 Form 20-F with regulatory requirements [12] V. Follow-up Arrangements - The first meeting of the new Board of Directors is scheduled for November 3, 2025, to elect key positions and appoint senior management, with resolutions to be disclosed promptly [13] Conclusion - The Board of Directors emphasized a commitment to shareholder responsibility and business development, aiming to enhance core competitiveness and deliver long-term value [14]

Core Insights - Conviva is positioned as the only platform that identifies consumer experience and engagement patterns, which enhances outcomes across applications, websites, and AI agents [1] Company Overview - Conviva specializes in analyzing consumer experience and engagement, providing insights that can lead to improved performance in various digital platforms [1] Industry Context - The focus on consumer experience and engagement is increasingly critical in the digital landscape, where companies seek to optimize interactions across multiple channels, including apps and AI [1]

Group 1 - The FX Super One Middle East launch event took place at the Armani Hotel in Burj Khalifa, Dubai, marking a significant milestone for the company [1] - Distinguished guests included representatives from the Qatari Government, Ajman Royal Family, and various investment groups, indicating strong regional interest and support [1] - Key executives from FF, including Global co-CEO Matthias Aydt and FX brand CEO Max Ma, were present, highlighting the leadership's commitment to the Middle East market [2] Group 2 - The event featured a forward-looking statement, suggesting that the company is focused on transparency regarding factors that may impact business and financial results [3]

Core Points - Visionary Holdings Inc. received a notification from Nasdaq regarding non-compliance with Listing Rule 5250(c)(1) due to a delay in filing its Annual Report on Form 20-F for the fiscal year ended March 31, 2025 [1] - The notification does not have an immediate effect on the listing or trading of the Company's shares, and the Company has 60 days to submit a compliance plan [2] - Visionary is actively working with its independent auditor to complete the audit process and file the Form 20-F as soon as possible [3] Company Overview - Visionary Holdings Inc. is a private education service provider based in Markham, Ontario, Canada, operating in both private and public education sectors [4]